Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,661 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative Risk of Incident Coronary Heart Disease Across Chronic Inflammatory Diseases.
Sinha A, Rivera AS, Chadha SA, Prasada S, Pawlowski AE, Thorp E, DeBerge M, Ramsey-Goldman R, Lee YC, Achenbach CJ, Lloyd-Jones DM, Feinstein MJ. Sinha A, et al. Among authors: lee yc. Front Cardiovasc Med. 2021 Nov 10;8:757738. doi: 10.3389/fcvm.2021.757738. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34859072 Free PMC article.
Differential Associations of Chronic Inflammatory Diseases With Incident Heart Failure.
Prasada S, Rivera A, Nishtala A, Pawlowski AE, Sinha A, Bundy JD, Chadha SA, Ahmad FS, Khan SS, Achenbach C, Palella FJ Jr, Ramsey-Goldman R, Lee YC, Silverberg JI, Taiwo BO, Shah SJ, Lloyd-Jones DM, Feinstein MJ. Prasada S, et al. Among authors: lee yc. JACC Heart Fail. 2020 Jun;8(6):489-498. doi: 10.1016/j.jchf.2019.11.013. Epub 2020 Apr 8. JACC Heart Fail. 2020. PMID: 32278678 Free PMC article.
Having More Tender Than Swollen Joints Is Associated With Worse Patient-Reported Outcomes in Patients With Early RA.
Meng CF, Lee YC, Schieir O, Valois MF, Butler MA, Boire G, Hazlewood G, Hitchon C, Keystone E, Tin D, Thorne C, Bessette L, Pope J, Bartlett SJ, Bykerk VP; Canadian Early Arthritis Cohort Investigators. Meng CF, et al. Among authors: lee yc. J Clin Rheumatol. 2024 Aug 1;30(5):193-199. doi: 10.1097/RHU.0000000000002091. Epub 2024 May 1. J Clin Rheumatol. 2024. PMID: 38689390
Pain levels and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a multicentre cross-sectional study.
Lee YC, Fox RS, Kwakkenbos L, Levis B, Carrier ME, Welling J, Sauvé M, Mouthon L, Benedetti A, Bartlett SJ, Varga J, Thombs BD; Scleroderma Patient-centered Intervention Network Investigators. Lee YC, et al. Lancet Rheumatol. 2021 Dec;3(12):e844-e854. doi: 10.1016/S2665-9913(21)00318-0. Lancet Rheumatol. 2021. PMID: 38287631
Protocol for the development of a tool to map systemic sclerosis pain sources, patterns, and management experiences: a Scleroderma Patient-centered Intervention Network patient-researcher partnership.
Dal Santo T, Golberg M, Nassar EL, Carrier ME, Hu S, Kwakkenbos L, Bartlett SJ, Fox RS, Lee YC, Varga J, Benedetti A, Thombs BD; Scleroderma Patient-centered Intervention Network Pain Patient Advisory Team. Dal Santo T, et al. Among authors: lee yc. BMC Rheumatol. 2024 Jun 21;8(1):28. doi: 10.1186/s41927-024-00398-3. BMC Rheumatol. 2024. PMID: 38907303 Free PMC article.
Intracerebral hemorrhage in CADASIL.
Hsu SL, Liao YC, Chung CP, Ihara M, Choi JC, Tang SC, Lee YC. Hsu SL, et al. Among authors: lee yc. J Chin Med Assoc. 2025 Jan 14. doi: 10.1097/JCMA.0000000000001206. Online ahead of print. J Chin Med Assoc. 2025. PMID: 39806999
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension.
Adams D, Wixner J, Polydefkis M, Berk JL, Conceição IM, Dispenzieri A, Peltier A, Ueda M, Bender S, Capocelli K, Jay PY, Yureneva E, Obici L; patisiran Global OLE study group. Adams D, et al. JAMA Neurol. 2025 Jan 13. doi: 10.1001/jamaneurol.2024.4631. Online ahead of print. JAMA Neurol. 2025. PMID: 39804640
Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients.
Cheng TC, Hung MC, Wang LH, Tu SH, Wu CH, Yen Y, Chen CL, Whang-Peng J, Lee WJ, Liao YC, Lee YC, Pan MH, Lin HK, Tzeng HE, Guo P, Chu CY, Chen LC, Ho YS. Cheng TC, et al. Among authors: lee yc. Biomark Res. 2025 Jan 9;13(1):7. doi: 10.1186/s40364-024-00715-5. Biomark Res. 2025. PMID: 39789599 Free PMC article.
5,661 results